Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
01/1996
01/04/1996WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
01/04/1996CA2192821A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
01/04/1996CA2192711A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same
01/03/1996EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors
01/03/1996EP0689836A1 Spirooxathiolane-quinuclidine derivative for the treatment of xerostomia
01/03/1996EP0689445A1 Aluminium containing pharmaceutical preparation with controlled release
01/03/1996EP0689437A1 Use of granisetron for the treatment of post-operative nausea and vomiting
01/03/1996EP0619806B1 Preparation of substituted piperidines
01/03/1996EP0505377B1 Muscarinic receptor antagonists
01/03/1996EP0401262B1 24r-scymnol, and preparation and use thereof
01/03/1996CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors
01/02/1996US5480998 Oxime derivative
01/02/1996US5480644 Collagen for injection in anus
01/02/1996CA2153083A1 Pharmaceutical compositions and a process for the preparation thereof
12/1995
12/31/1995CA2152982A1 Oral care products containing zinc-polyamine complex
12/29/1995CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them
12/28/1995WO1995035372A1 5-lipoxygenase-activating protein ii
12/28/1995WO1995035314A1 Thiazolidine derivatives, their preparation and drugs containing same
12/28/1995WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
12/28/1995WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
12/28/1995WO1995035276A1 Metalloproteinase inhibitors
12/28/1995WO1995035275A1 Metalloproteinase inhibitors
12/28/1995CA2193692A1 Metalloproteinase inhibitors
12/28/1995CA2193691A1 Metalloproteinase inhibitors
12/28/1995CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
12/28/1995CA2152420A1 Therapeutic agent for the treatment of xerostomia
12/27/1995EP0688226A1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity
12/27/1995EP0688211A1 Methods and compositions for inhibition of angiogenesis
12/27/1995EP0607178A4 Methods for the selection, separation and fusion of cells.
12/27/1995EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity
12/27/1995CN1113772A Chinese drug powder for curing hepatitis B and its preparing method
12/26/1995US5478949 Reacting the starting carbazolone with dialkyl oxalate, then formaldehyde and 2-methylimidazole
12/26/1995US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators
12/26/1995US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors
12/26/1995US5478858 Respiratory system disorders, gastrointestinal disorders
12/26/1995US5478845 Piperidine derivatives
12/26/1995CA2028746C Pharmaceutical compositions and methods for treating the symptoms of overindulgence
12/21/1995WO1995034585A1 Process for removing bile salts from a patient and alkylated compositions therefor
12/21/1995WO1995034563A1 Pyrazolo and pyrrolopyridines
12/21/1995WO1995034555A1 Benzimidazolone derivatives with central dopaminergic activity
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/21/1995WO1995034300A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same
12/20/1995EP0687252A1 2-phenoxyethylamine derivatives, their preparation and their therapeutical use
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/20/1995EP0687174A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation
12/20/1995EP0596049A4 Defoaming composition
12/19/1995US5476954 Condensing hydroxyl protected taxane derivative with oxazolidine derivative, decyclizing in acid medium, reacting butoxycarbonyl or benzoyl radical with amine, deprotecting, isolating, purifying product
12/19/1995US5476858 Use of carbostyril to increase somatostatin or for inhibiting decrease of somatostatin to treat diseases related thereto
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/19/1995US5476669 Administering a bismuth compound, a first antibiotic from tetracycline and penicillin groups and a second antibiotic which is metronidazole; for preventing recurrence of duodenal ulcer
12/19/1995CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/14/1995WO1995033830A1 Bmp-9 compositions
12/14/1995WO1995033765A1 Conformationally constrained backbone cyclized peptide analog
12/14/1995WO1995033763A1 Novel elastase inhibitors
12/14/1995WO1995033752A1 Endothelin receptor antagonists
12/14/1995WO1995033750A1 Corticotropin releasing factor antagonists
12/14/1995WO1995033744A1 Tachykinin (nk1) receptor antagonists
12/14/1995WO1995033712A1 Anti-inflammatory compounds
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033478A1 Acylated enol derivatives as prodrugs of elastase inhibitors
12/14/1995WO1995033473A1 Extracts of stephania tetrandra for inhibition of interleukin-6 production
12/14/1995WO1995033470A1 Composition for dental use comprising krill enzyme
12/14/1995WO1995033461A1 Anti-inflammatory compounds
12/14/1995CA2192332A1 Composition for dental use comprising krill enzyme
12/14/1995CA2192305A1 Conformationally constrained backbone cyclized peptide analogs
12/14/1995CA2187531A1 Tachykinin (nk1) receptor antagonists
12/13/1995EP0686629A2 Cyclohexyl tachykinine receptor antagonists
12/13/1995EP0686194A1 Harp family growth factors, preparation methods therefor and uses thereof
12/13/1995EP0686034A1 Bisacodyl dosage form
12/13/1995CN1113236A Non-peptidyl tachykinin receptor antagonists
12/12/1995US5475106 Agonist for cholecystokinin and gastrin receptors; nervous system, gastrointestinal disorders
12/12/1995US5475028 Antihepatitis, antiulcer agents
12/12/1995US5475015 Benzimidazole derivatives, their preparation and pharmaceutical use
12/12/1995US5475000 3-(substituted tetrazolyl)-4-oxo-4H-pyrido-[1,2-a]pyrimidines, salts thereof, pharmaceutical compositions containing them and process for preparing same
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474987 Methods of using low molecular weight heparins treatment of pathological processes
12/11/1995CA2151113A1 Imidazolinyl tachykinin receptor antagonists
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists
12/07/1995WO1995033053A1 Hepatitis c virus asialoglycoproteins
12/07/1995WO1995032949A1 Gastrin and cck antagonists
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032944A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
12/07/1995WO1995032728A1 Inhibition of attachment of h. influenzae to human cells
12/07/1995WO1995032718A1 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995CA2190610A1 Inhibition of attachment of h. influenzae to human cells
12/07/1995CA2190265A1 Hepatitis c virus asialoglycoproteins
12/07/1995CA2166988A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives
12/07/1995CA2166987A1 Novel substituted benzimidazoles
12/06/1995EP0685486A1 Method of manufacturing lactulose anhydride
12/06/1995EP0685475A1 Amino-benzofuryl-and thienyl-derivatives
12/06/1995EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives
12/06/1995EP0685463A1 Indolin-2-one derivative
12/06/1995EP0685233A2 Thieno[1,5]benzodiazepine for treating gastrointestinal conditions
12/06/1995EP0684949A1 Chemical compounds
12/06/1995EP0684947A1 Amide compounds with pharmacological activity
12/06/1995EP0684816A1 5-ht 2? receptor antagonist compositions useful in treating venous conditions
12/06/1995EP0520021B1 Pharmaceutical compositions
1 ... 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 ... 1258